Roger’s sarcoma experience
Our aspiration is to deliver more treatment options for people with cancer today, tomorrow and beyond. Roger, who lives with sarcoma, sheds light on why this is so important.
Search
Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS™ (sotorasib), a KRASG12C Inhibitor
Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS™ (sotorasib), a KRASG12C Inhibitor
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
Empowering Patients
Empowering Patients
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
Netherlands
Netherlands
Information Technology
IT
Day3 Neo New Hire
Day4 Neo New Hire
2024 Company Holidays
2024 BI Puerto Rico Holiday
Enabling Today's Science PDF
company-holidays.pdf
2019_holiday_calendars_pr.pdf
biusa-hp-iu-dress-for-your-day-guidelines.pdf
Company Holidays
Dress For Your Day Guidelines
Enabling Today’s Science
Enabling Today’s Science
How Simulation is Changing the Game in Biotherapeutic Drug Development
How Simulation is Changing the Game in Biotherapeutic Drug Development
Why is Real-World Evidence Important
Worldwide Partnering Contacts
Worldwide Partnering Contacts
Emerging Talent
At Boehringer Ingelheim, we know how important it is to lay the right foundations in your career and build on them with care and support.
Onboarding
Onboarding
Cafeteria Crews Cook for Community | Boehringer Ingelheim US
Read more on how BI cafeteria crews are supporting their communities by cooking over 500 meals a day for first responders & others during the pandemic.
More Health: For People & Animals
More Health: For People & Animals